Molecular Imaging Device-EMEA Market Status and Trend Report 2013-2023
![](/report_cover/10724/molecular-imaging-device-emea-market-status-n-trend-report-2013-2023_en.gif)
Report Summary
Molecular Imaging Device-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Imaging Device industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Molecular Imaging Device 2013-2017, and development forecast 2018-2023
Main market players of Molecular Imaging Device in EMEA, with company and product introduction, position in the Molecular Imaging Device market
Market status and development trend of Molecular Imaging Device by types and applications
Cost and profit status of Molecular Imaging Device, and marketing status
Market growth drivers and challenges
The report segments the EMEA Molecular Imaging Device market as:
EMEA Molecular Imaging Device Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Molecular Imaging Device Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Nuclear Medicine
PET/CT
PET Radiopharmacy
Other
EMEA Molecular Imaging Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Cardio and vascular
Neurology
Others
EMEA Molecular Imaging Device Market: Players Segment Analysis (Company and Product introduction, Molecular Imaging Device Sales Volume, Revenue, Price and Gross Margin):
Cardiarc
Digirad
Gamma Medica
GE
Gvi Medical Devices
Hitachi
Mediso
CMR Naviscan
Neurologica
Neusoft
BC Technical
Philips
Positron
Siemens
Biosensors International
Toshiba
Trivitron Healthcare
Molecular Devices
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Molecular Imaging Device-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Imaging Device industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Molecular Imaging Device 2013-2017, and development forecast 2018-2023
Main market players of Molecular Imaging Device in EMEA, with company and product introduction, position in the Molecular Imaging Device market
Market status and development trend of Molecular Imaging Device by types and applications
Cost and profit status of Molecular Imaging Device, and marketing status
Market growth drivers and challenges
The report segments the EMEA Molecular Imaging Device market as:
EMEA Molecular Imaging Device Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Molecular Imaging Device Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Nuclear Medicine
PET/CT
PET Radiopharmacy
Other
EMEA Molecular Imaging Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Cardio and vascular
Neurology
Others
EMEA Molecular Imaging Device Market: Players Segment Analysis (Company and Product introduction, Molecular Imaging Device Sales Volume, Revenue, Price and Gross Margin):
Cardiarc
Digirad
Gamma Medica
GE
Gvi Medical Devices
Hitachi
Mediso
CMR Naviscan
Neurologica
Neusoft
BC Technical
Philips
Positron
Siemens
Biosensors International
Toshiba
Trivitron Healthcare
Molecular Devices
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MOLECULAR IMAGING DEVICE
1.1 Definition of Molecular Imaging Device in This Report
1.2 Commercial Types of Molecular Imaging Device
1.2.1 Nuclear Medicine
1.2.2 PET/CT
1.2.3 PET Radiopharmacy
1.2.4 Other
1.3 Downstream Application of Molecular Imaging Device
1.3.1 Oncology
1.3.2 Cardio and vascular
1.3.3 Neurology
1.3.4 Others
1.4 Development History of Molecular Imaging Device
1.5 Market Status and Trend of Molecular Imaging Device 2013-2023
1.5.1 EMEA Molecular Imaging Device Market Status and Trend 2013-2023
1.5.2 Regional Molecular Imaging Device Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Imaging Device in EMEA 2013-2017
2.2 Consumption Market of Molecular Imaging Device in EMEA by Regions
2.2.1 Consumption Volume of Molecular Imaging Device in EMEA by Regions
2.2.2 Revenue of Molecular Imaging Device in EMEA by Regions
2.3 Market Analysis of Molecular Imaging Device in EMEA by Regions
2.3.1 Market Analysis of Molecular Imaging Device in Europe 2013-2017
2.3.2 Market Analysis of Molecular Imaging Device in Middle East 2013-2017
2.3.3 Market Analysis of Molecular Imaging Device in Africa 2013-2017
2.4 Market Development Forecast of Molecular Imaging Device in EMEA 2018-2023
2.4.1 Market Development Forecast of Molecular Imaging Device in EMEA 2018-2023
2.4.2 Market Development Forecast of Molecular Imaging Device by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Molecular Imaging Device in EMEA by Types
3.1.2 Revenue of Molecular Imaging Device in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Molecular Imaging Device in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Imaging Device in EMEA by Downstream Industry
4.2 Demand Volume of Molecular Imaging Device by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Imaging Device by Downstream Industry in Europe
4.2.2 Demand Volume of Molecular Imaging Device by Downstream Industry in Middle East
4.2.3 Demand Volume of Molecular Imaging Device by Downstream Industry in Africa
4.3 Market Forecast of Molecular Imaging Device in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR IMAGING DEVICE
5.1 EMEA Economy Situation and Trend Overview
5.2 Molecular Imaging Device Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR IMAGING DEVICE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Molecular Imaging Device in EMEA by Major Players
6.2 Revenue of Molecular Imaging Device in EMEA by Major Players
6.3 Basic Information of Molecular Imaging Device by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Imaging Device Major Players
6.3.2 Employees and Revenue Level of Molecular Imaging Device Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR IMAGING DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Cardiarc
7.1.1 Company profile
7.1.2 Representative Molecular Imaging Device Product
7.1.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Cardiarc
7.2 Digirad
7.2.1 Company profile
7.2.2 Representative Molecular Imaging Device Product
7.2.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Digirad
7.3 Gamma Medica
7.3.1 Company profile
7.3.2 Representative Molecular Imaging Device Product
7.3.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Gamma Medica
7.4 GE
7.4.1 Company profile
7.4.2 Representative Molecular Imaging Device Product
7.4.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of GE
7.5 Gvi Medical Devices
7.5.1 Company profile
7.5.2 Representative Molecular Imaging Device Product
7.5.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Gvi Medical Devices
7.6 Hitachi
7.6.1 Company profile
7.6.2 Representative Molecular Imaging Device Product
7.6.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Hitachi
7.7 Mediso
7.7.1 Company profile
7.7.2 Representative Molecular Imaging Device Product
7.7.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Mediso
7.8 CMR Naviscan
7.8.1 Company profile
7.8.2 Representative Molecular Imaging Device Product
7.8.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of CMR Naviscan
7.9 Neurologica
7.9.1 Company profile
7.9.2 Representative Molecular Imaging Device Product
7.9.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Neurologica
7.10 Neusoft
7.10.1 Company profile
7.10.2 Representative Molecular Imaging Device Product
7.10.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Neusoft
7.11 BC Technical
7.11.1 Company profile
7.11.2 Representative Molecular Imaging Device Product
7.11.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of BC Technical
7.12 Philips
7.12.1 Company profile
7.12.2 Representative Molecular Imaging Device Product
7.12.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Philips
7.13 Positron
7.13.1 Company profile
7.13.2 Representative Molecular Imaging Device Product
7.13.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Positron
7.14 Siemens
7.14.1 Company profile
7.14.2 Representative Molecular Imaging Device Product
7.14.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Siemens
7.15 Biosensors International
7.15.1 Company profile
7.15.2 Representative Molecular Imaging Device Product
7.15.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Biosensors International
7.16 Toshiba
7.17 Trivitron Healthcare
7.18 Molecular Devices
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR IMAGING DEVICE
8.1 Industry Chain of Molecular Imaging Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR IMAGING DEVICE
9.1 Cost Structure Analysis of Molecular Imaging Device
9.2 Raw Materials Cost Analysis of Molecular Imaging Device
9.3 Labor Cost Analysis of Molecular Imaging Device
9.4 Manufacturing Expenses Analysis of Molecular Imaging Device
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR IMAGING DEVICE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Molecular Imaging Device in This Report
1.2 Commercial Types of Molecular Imaging Device
1.2.1 Nuclear Medicine
1.2.2 PET/CT
1.2.3 PET Radiopharmacy
1.2.4 Other
1.3 Downstream Application of Molecular Imaging Device
1.3.1 Oncology
1.3.2 Cardio and vascular
1.3.3 Neurology
1.3.4 Others
1.4 Development History of Molecular Imaging Device
1.5 Market Status and Trend of Molecular Imaging Device 2013-2023
1.5.1 EMEA Molecular Imaging Device Market Status and Trend 2013-2023
1.5.2 Regional Molecular Imaging Device Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Imaging Device in EMEA 2013-2017
2.2 Consumption Market of Molecular Imaging Device in EMEA by Regions
2.2.1 Consumption Volume of Molecular Imaging Device in EMEA by Regions
2.2.2 Revenue of Molecular Imaging Device in EMEA by Regions
2.3 Market Analysis of Molecular Imaging Device in EMEA by Regions
2.3.1 Market Analysis of Molecular Imaging Device in Europe 2013-2017
2.3.2 Market Analysis of Molecular Imaging Device in Middle East 2013-2017
2.3.3 Market Analysis of Molecular Imaging Device in Africa 2013-2017
2.4 Market Development Forecast of Molecular Imaging Device in EMEA 2018-2023
2.4.1 Market Development Forecast of Molecular Imaging Device in EMEA 2018-2023
2.4.2 Market Development Forecast of Molecular Imaging Device by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Molecular Imaging Device in EMEA by Types
3.1.2 Revenue of Molecular Imaging Device in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Molecular Imaging Device in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Imaging Device in EMEA by Downstream Industry
4.2 Demand Volume of Molecular Imaging Device by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Imaging Device by Downstream Industry in Europe
4.2.2 Demand Volume of Molecular Imaging Device by Downstream Industry in Middle East
4.2.3 Demand Volume of Molecular Imaging Device by Downstream Industry in Africa
4.3 Market Forecast of Molecular Imaging Device in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR IMAGING DEVICE
5.1 EMEA Economy Situation and Trend Overview
5.2 Molecular Imaging Device Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR IMAGING DEVICE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Molecular Imaging Device in EMEA by Major Players
6.2 Revenue of Molecular Imaging Device in EMEA by Major Players
6.3 Basic Information of Molecular Imaging Device by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Imaging Device Major Players
6.3.2 Employees and Revenue Level of Molecular Imaging Device Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR IMAGING DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Cardiarc
7.1.1 Company profile
7.1.2 Representative Molecular Imaging Device Product
7.1.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Cardiarc
7.2 Digirad
7.2.1 Company profile
7.2.2 Representative Molecular Imaging Device Product
7.2.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Digirad
7.3 Gamma Medica
7.3.1 Company profile
7.3.2 Representative Molecular Imaging Device Product
7.3.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Gamma Medica
7.4 GE
7.4.1 Company profile
7.4.2 Representative Molecular Imaging Device Product
7.4.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of GE
7.5 Gvi Medical Devices
7.5.1 Company profile
7.5.2 Representative Molecular Imaging Device Product
7.5.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Gvi Medical Devices
7.6 Hitachi
7.6.1 Company profile
7.6.2 Representative Molecular Imaging Device Product
7.6.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Hitachi
7.7 Mediso
7.7.1 Company profile
7.7.2 Representative Molecular Imaging Device Product
7.7.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Mediso
7.8 CMR Naviscan
7.8.1 Company profile
7.8.2 Representative Molecular Imaging Device Product
7.8.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of CMR Naviscan
7.9 Neurologica
7.9.1 Company profile
7.9.2 Representative Molecular Imaging Device Product
7.9.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Neurologica
7.10 Neusoft
7.10.1 Company profile
7.10.2 Representative Molecular Imaging Device Product
7.10.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Neusoft
7.11 BC Technical
7.11.1 Company profile
7.11.2 Representative Molecular Imaging Device Product
7.11.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of BC Technical
7.12 Philips
7.12.1 Company profile
7.12.2 Representative Molecular Imaging Device Product
7.12.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Philips
7.13 Positron
7.13.1 Company profile
7.13.2 Representative Molecular Imaging Device Product
7.13.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Positron
7.14 Siemens
7.14.1 Company profile
7.14.2 Representative Molecular Imaging Device Product
7.14.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Siemens
7.15 Biosensors International
7.15.1 Company profile
7.15.2 Representative Molecular Imaging Device Product
7.15.3 Molecular Imaging Device Sales, Revenue, Price and Gross Margin of Biosensors International
7.16 Toshiba
7.17 Trivitron Healthcare
7.18 Molecular Devices
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR IMAGING DEVICE
8.1 Industry Chain of Molecular Imaging Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR IMAGING DEVICE
9.1 Cost Structure Analysis of Molecular Imaging Device
9.2 Raw Materials Cost Analysis of Molecular Imaging Device
9.3 Labor Cost Analysis of Molecular Imaging Device
9.4 Manufacturing Expenses Analysis of Molecular Imaging Device
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR IMAGING DEVICE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference